title: Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation.
authors.affiliation: Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Motohashi
authors.affiliation: Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Fujisawa
authors.affiliation: Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Onizuka
authors.affiliation: Division of Hematology, Saitama Medical Center, Jichi Medical University, Shimotsuke, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Kako
authors.affiliation: Division of Hematology, Department of Clinical Cell Biology, Chiba University Graduate School of Medicine, Chiba, Japan.
authors.forename: E
authors.initials: E
authors.lastname: Sakaida
authors.affiliation: Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Shono
authors.affiliation: Division of Hematology, Jichi Medical University, Shimotsuke, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Tatara
authors.affiliation: Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Doki
authors.affiliation: Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Mori
authors.affiliation: Leukemia Research Center, Gunmaken Saiseikai Maebashi Hospital, Maebashi, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Sakura
authors.affiliation: Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Aotsuka
authors.affiliation: Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
authors.forename: E
authors.initials: E
authors.lastname: Fuji
authors.affiliation: Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Tomita
authors.affiliation: Department of Hemato-Oncology, Saitama International Medical Center, Saitama Medical University, Saitama, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Kawai
authors.affiliation: Department of Hematology, Gunma University Hospital, Maebashi, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Saitoh
authors.affiliation: Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Usuki
authors.affiliation: Department of Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Taguchi
authors.affiliation: Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Watanabe
authors.affiliation: Department of Hematology, Nihon University Itabashi Hospital, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Kobayashi
authors.affiliation: Division of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Yano
authors.affiliation: Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kanamori
authors.affiliation: Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Takahashi
authors.affiliation: Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Okamoto
mesh_terms: D064591:Allografts; D000818:Animals; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D019337:Hematologic Neoplasms / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D017710:Lymphocyte Transfusion / Q000009:adverse effects; D008297:Male; D051379:Mice; D009190:Myelodysplastic Syndromes / Q000628:therapy; D012008:Recurrence; D012189:Retrospective Studies; D013997:Time Factors; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome; D014916:Whole-Body Irradiation / Q000009:adverse effects / Q000379:methods*
chemical_list: D016207:Cytokines; D003520:Cyclophosphamide